. . , "! !" . ( , , ) . → → , → → · . 3) 4) . . ' ' () , () . . , . . . . , . , , , . 0.1 0 , . . . , . . 0.001 . , ( ) ( ) . . . . , . Kitayama, S., Park, J., Miyamoto, Y.,… [+269 chars]
70 . . [=] . . 70 · . . . . , . 70 12 . 1. () . . 20~40 1.0%, 50 3.5% . 60 12.1% 70 28.8%. 80 54.4% . 70 . . , , . 70 . 2., , 70 65 (4 1) () . , . . 70 1~2 . , . . 3. . . , . 70 . . , … [+378 chars]
(27) EBS ‘ ’ 2 1 ' ' . [EBS ] ' 1- ' . ? . , . () . 38 . ‘ ’ . 95% , . 2 . , . ! . EBS < – 1. > . 30 . . . ? . . . (), . ? 3 () . . . , , . 10 , . , . 50 . , ? . . , … [+97 chars]
[] = ()524‘, ‘IDIS (Infectious Disease Summit) Week’ . 524274IDIS Week . . 27%69%.1202022. , , ., 23. 201365., 1020203. , (2018-2021), , 3, 19A . 3 (n=16; 13.8%)19A (n=11; 9.5%) . , 3(n = 1… [+161 chars]
D 2 . [=] D 2 . (BMJ) 26() . D (Eldecalcitol) 2 . 2013~2019 3 1256 . 30 61. 46% 59% 2 . 3 3 . 630 626 . 12.5% 14% . 23%, 20%. 2 . . D . , . 48000 2 . 2045 7 . 5 . 2 . . BMJ . D , . “ D ,… [+113 chars]
[= ] 5 29 (WGO, World Gastroenterology Organisation) ‘ ’. 70% . , , , . , . 100g 2.3g , . ‘ ’ . , . . 4 , . , ‘’ . 57% . . , . , . ‘(α- β-)’ . , . , A, C, , . ‘’ ‘ ’ . . . gorgeo… [+16 chars]
[ ] . . D . D , , · . D , .D , . , . . , . 19 .D . 2017 , 86.8%, 93.3% D . 2010 78%, 2015 6~20 50% D . D ( 200IU, (NIH) 600IU) 5~30 . D . , D , , , , , , , . D .D , . , D .
[=] = (DGIST) 28 .(synapse) (synaptic adhesion protein) · . 10 . · . . , . -- . DGIST " 10 " " . " .DGIST , 1 DGIST . ' (Trends in Neurosciences)' 513 DGIST . june@newsis.com < . - .>… [+6 chars]
, ? . , . (), () . , · . 1 3 . . . , . . , . . . , . 100% . . () . (Bell palsy) . . . . . . . . . . , (), () . 1~2 , . . , () . , () . () () . . , . , .
. [=] 7 . , , , , , , . (Lifes simple 7), . . , . 8823 2738 30 11561 . 54. 1 9% . , 43% . 30% . 6% 17% . 7 . 0 , 14 . 8.3, 6.6. . 5 , 3 . APOE APOE e4 1 . 27.9% APOE e4 , 40.4% APOE e4 .… [+81 chars]
. . , . · 12 . 12 . < > , . . , . . 2009 , . . . M. , . . , . © (cancer answer) 0
, ? . , . (), () . , · . 1 3 . . . , . . , . . . , . 100% . . () . (Bell palsy) . . . . . . . . . . , (), () . 1~2 , . . , () . , () . () () . . , . , .